Endovia Health Sciences, Inc. balance sheet
At the end of fiscal 2025, Endovia Health Sciences, Inc. had total assets of $965,694, total liabilities of $16.3m and shareholders' equity of −$15.3m. It held $281,435 in cash against $6.2m of debt.
Balance sheet
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | — | — | — | — | 1 | 0 | 0 | 4 | 4 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 |
| Inventory | — | — | — | — | — | — | — | 0 | 0 | 1 | 2 | 4 | 2 | 0 | 0 | 0 |
| Total current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 4 | 2 | 1 | 1 |
| Goodwill | — | — | — | — | — | — | — | — | — | 6 | 0 | 0 | 0 | — | — | — |
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 9 | 16 | 17 | 10 | 3 | 1 | 1 |
| Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 4 | 4 | 5 | 4 |
| Total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 5 | 6 | 5 | 15 | 19 | 16 | 17 |
| Short-term debt | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Long-term debt | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 2 | 0 | — |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 3 | 4 | 8 | 12 | 6 | 6 |
| Total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 9 | 8 | 8 | 16 | 21 | 16 | 17 |
| Shareholders' equity | −0 | −0 | −0 | −0 | −0 | 0 | −0 | −8 | −10 | −9 | 9 | 9 | −6 | −19 | −15 | −16 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | — | 8 | — | 9 | — | — | — | — | — | — |
| Shares outstanding | — | — | — | — | — | — | — | — | — | 63m | — | — | — | 2m | 2m | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Total current assets | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Goodwill | 0 | — | — | — | — | — | — | — |
| Total assets | 8 | 3 | 3 | 22 | 22 | 1 | 1 | 1 |
| Accounts payable | 6 | 4 | 6 | 7 | 7 | 5 | 5 | 4 |
| Total current liabilities | 18 | 19 | 20 | 13 | 16 | 16 | 17 | 17 |
| Long-term debt | 1 | 2 | 2 | 0 | 0 | 0 | 0 | — |
| Total debt | 1 | 2 | 2 | 0 | 0 | 0 | 0 | — |
| Total liabilities | 19 | 21 | 23 | 14 | 16 | 16 | 17 | 17 |
| Shareholders' equity | −11 | −19 | −20 | 9 | 7 | −15 | −16 | −16 |
| Shares outstanding | 44m | 2m | 2m | 2m | 2m | — | 3m | — |
Compare with peers
- LQR House Inc. balance sheet
- Innovation Beverage Group Ltd balance sheet
- Epsium Enterprise Ltd balance sheet
- Agencia Comercial Spirits Ltd. balance sheet
- Meiwu Technology Co Ltd balance sheet
Head to head: EDVA vs YHCEDVA vs IBGEDVA vs EPSM
More: Beverages stocks compared, Consumer Staples sector, rankings of US companies